We are live on
!
Find out more
Marex Group Portfolio holdings
AUM
$23.6B
Turnover
47.63%
1-Year Est. Return
57.16%
This Fund
S&P 500
This Quarter
Est. Return
+4.95%
1 Year Est. Return
+57.16%
3 Year Est. Return
+254.23%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$15.8B
AUM Growth
-$67.5M
(-0.42%)
Cap. Flow
+$1.48B
Cap. Flow
% of AUM
9.36%
Top 10 Holdings %
Top 10 Hldgs %
30.69%
Holding
1,298
New
335
Increased
347
Reduced
276
Closed
290
Avg Time Held Equity + Options
0.7
years
Top 10 Avg Time Held Equity + Options
0.2
years
Top 20 Avg Time Held Equity + Options
0.5
years
Avg Time Held Equity only
0.7
years
Top 10 Avg Time Held Equity only
0.6
years
Top 20 Avg Time Held Equity only
0.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lumentum
LITE
|
+$471M |
| 2 |
Sandisk
SNDK
|
+$313M |
| 3 |
Goldman Sachs
GS
|
+$179M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$144M |
| 5 |
Eli Lilly
LLY
|
+$113M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$304M |
| 2 |
UnitedHealth
UNH
|
+$174M |
| 3 |
NVIDIA
NVDA
|
+$137M |
| 4 |
Home Depot
HD
|
+$131M |
| 5 |
Netflix
NFLX
|
+$107M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 48.11% |
| 2 | Technology | 25% |
| 3 | Financials | 9.44% |
| 4 | Consumer Discretionary | 4.76% |
| 5 | Healthcare | 4.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
526
JBS N.V.
JBS
$41.8B
| $718K | ﹤0.01% |
40,000
| – | – |
2025 Q3
2 quarters
|
|
527
Agilent Technologies
A
$49.5B
| $716K | ﹤0.01% |
+6,282
| New | +$797K |
2026 Q1
0 quarters
|
|
528
Roku
ROKU
$23B
| $708K | ﹤0.01% |
7,483
-22,385
| -75% | -$2.18M |
2022 Q4
13 quarters
|
|
529
Alkermes
ALKS
$6.73B
| $703K | ﹤0.01% |
19,891
-24,960
| -56% | -$774K |
2025 Q3
2 quarters
|
|
530
PUT
Vertiv
VRT
$82.7B
| $702K | ﹤0.01% |
2,800
| – | – |
2025 Q3
2 quarters
|
|
531
Morgan Stanley China A Share Fund
CAF
$228M
| $700K | ﹤0.01% |
40,000
| – | – |
2025 Q4
1 quarter
|
|
532
Datadog
DDOG
$95.6B
| $695K | ﹤0.01% |
5,885
+3,593
| +157% | +$444K |
2025 Q3
2 quarters
|
|
533
State Street Technology Select Sector SPDR ETF
XLK
$125B
| $689K | ﹤0.01% |
+5,184
| New | +$731K |
2026 Q1
0 quarters
|
|
534
CALL
VICI Properties
VICI
$25.8B
| $683K | ﹤0.01% |
25,000
+5,000
| +25% | +$143K |
2025 Q2
3 quarters
|
|
535
Match Group
MTCH
$10.1B
| $681K | ﹤0.01% |
22,172
+135
| +0.6% | +$4.21K |
2022 Q4
13 quarters
|
|
536
Teva Pharmaceutical Industries Limited
TEVA
$47.9B
| $679K | ﹤0.01% |
22,529
-3,518
| -14% | -$113K |
2025 Q1
4 quarters
|
|
537
PUT
Infosys
INFY
$49.1B
| $676K | ﹤0.01% |
+50,000
| New | +$783K |
2026 Q1
0 quarters
|
|
538
Royal Caribbean
RCL
$74.9B
| $672K | ﹤0.01% |
2,443
-1,451
| -37% | -$432K |
2025 Q3
2 quarters
|
|
539
Angi Inc
ANGI
$262M
| $671K | ﹤0.01% |
98,016
+34,999
| +56% | +$351K |
2025 Q2
3 quarters
|
|
540
Charter Communications
CHTR
$12.6B
| $671K | ﹤0.01% |
3,106
+33
| +1% | +$7.15K |
2025 Q3
2 quarters
|
|
541
Zeta Global
ZETA
$8.42B
| $669K | ﹤0.01% |
+42,053
| New | +$779K |
2026 Q1
0 quarters
|
|
542
Amprius Technologies
AMPX
$1.23B
| $669K | ﹤0.01% |
+39,708
| New | +$518K |
2026 Q1
0 quarters
|
|
543
iShares Expanded Tech-Software Sector ETF
IGV
$14.6B
| $669K | ﹤0.01% |
+8,362
| New | +$740K |
2026 Q1
0 quarters
|
|
544
Air Products & Chemicals
APD
$66B
| $668K | ﹤0.01% |
+2,298
| New | +$634K |
2026 Q1
0 quarters
|
|
545
Southern Copper
SCCO
$170B
| $663K | ﹤0.01% |
+3,939
| New | +$712K |
2026 Q1
0 quarters
|
|
546
Alnylam Pharmaceuticals
ALNY
$31.3B
| $662K | ﹤0.01% |
+2,000
| New | +$681K |
2026 Q1
0 quarters
|
|
547
Artivion
AORT
$1.07B
| $659K | ﹤0.01% |
+18,000
| New | +$710K |
2026 Q1
0 quarters
|
|
548
Nokia
NOK
$53.6B
| $658K | ﹤0.01% |
+81,898
| New | +$601K |
2026 Q1
0 quarters
|
|
549
Stryker
SYK
$112B
| $658K | ﹤0.01% |
2,002
-63
| -3% | -$22.6K |
2023 Q2
11 quarters
|
|
550
Invesco KBW Bank ETF
KBWB
$6.19B
| $658K | ﹤0.01% |
8,313
-1,569
| -16% | -$131K |
2025 Q4
1 quarter
|
|
Similar funds
Marex Group's Q1 2026 Portfolio in Review
As of Q1 2026, Marex Group held 1,298 positions worth $15.8B, down 0.42% from $15.9B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Marex Group deployed $1.48B of net new capital in Q1 2026, opening 335 new positions and adding to 347 existing holdings. Its largest new stake was Lumentum: 857,171 shares worth $602M.
By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, down from 51% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $304M trimmed.
- Marex Group's largest Q1 2026 buy was Lumentum: 857,171 shares worth $602M.
- Marex Group added most to Goldman Sachs in Q1 2026, an estimated $179M increase.
- Marex Group's biggest Q1 2026 reduction was Meta Platforms (Facebook), cutting an estimated $304M.
- Marex Group fully exited Dycom Industries in Q1 2026, selling an estimated $13.3M.
- Marex Group's ten largest holdings make up 31% of its $15.8B portfolio in Q1 2026.
- Marex Group opened 335 new positions and closed 290 in Q1 2026.
- Marex Group's portfolio value fell 0.42% quarter-over-quarter to $15.8B.
Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.